Regulatory Approval

In a historic move, the SEC has approved Paxos as the first blockchain-native clearing agency, signaling a major shift for Wall Street's core infrastructure.

BeOne Medicines' immunotherapy TEVIMBRA gains key reimbursement nods, paving the way for Canada's first funded option for a rare head and neck cancer.

France's largest-ever renewable project moves forward, promising green power for a million homes. But it's a high-stakes gamble for the Normandy region.

As AI regulations tighten, VidCruiter's #1 spot on Gartner Peer Insights shows why customer-verified, auditable hiring platforms are now winning.

Air taxi operator Hopscotch Go advances toward public trading, a move to fund expansion in the rapidly growing regional air mobility market.

With backing from GV and Dexcom, Signos is using AI and OTC glucose monitors to offer a new path for sustainable weight management beyond GLP-1 drugs.

A new partnership between biotech leader Debut and Amazonian expert Natura aims to revolutionize anti-aging skincare with AI-discovered ingredients.

EOM Pharmaceutical gets FDA clearance for a trial on EOM613, a potential first-in-class treatment for cancer cachexia, a severe wasting syndrome.

The radiology platform's new accreditation enables delegated credentialing, helping hospitals combat radiologist shortages and streamline critical care delivery.

Dutch CDMO Intravacc's new French tax credit approval offers a major financial boost for biotech partners, aiming to accelerate vaccine R&D in Europe.

Vanda Pharmaceuticals' rare disease drug gets a key designation in Japan, unlocking major incentives and promising a new treatment for a severe skin disease.

Positive Phase 3 data for oral drug filgotinib offers new hope for thousands of axial spondyloarthritis patients who fail to respond to current therapies.

Disciplined Growth Acquisition Corp. has priced its $150M IPO, targeting FinTech, Aerospace, and Clean Tech in a demanding and mature SPAC market.

Burtech Acquisition Corp II closes an $80 million IPO, joining a reformed SPAC market. Can veteran investor Shahal M. Khan find a winner this time?

In a landmark move, FINRA has authorized Ohanae Securities to custody and clear crypto asset securities, paving the way for a new era of regulated digital markets.

A major merger backed by US private equity creates a new powerhouse in Romania's complex care market, raising questions about access and physician roles.

Ionetix wins FDA approval for its generic prostate cancer imaging agent, a move set to boost access and shake up the competitive radiopharmaceutical market.

Forcepoint extends its data security platform to Claude Enterprise, aiming to solve the growing challenges of shadow AI, data exposure, and regulatory compliance.

With new funding from Bregal Sagemount, LSPedia is set to advance its AI tools, moving beyond compliance to build a smarter, safer pharma supply chain.

DePuy Synthes acquires novel radiofrequency tracking to move beyond the line-of-sight limits and invasive pins of current robotic joint surgery systems.